Activation of IP prostanoid receptors prevents cardiomyocyte hypertrophy via cAMP-dependent signaling. (Q44836452)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Activation of IP prostanoid receptors prevents cardiomyocyte hypertrophy via cAMP-dependent signaling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

A C Rosenkranz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

L P Huynh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

T Stephenson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

D M Kaye

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

G J Dusting

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

8 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology Heart and Circulatory Physiology

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

H1179-85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Prostacyclin and vascular function: implications for hypertension and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Stress-activated protein kinases in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Effects of the prostanoids on the proliferation or hypertrophy of cultured murine aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Signaling pathways in cardiac myocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Contributions of protein kinase A anchoring proteins to compartmentation of cAMP signaling in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Calcineurin inhibition and cardiac hypertrophy: a matter of balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Left ventricular hypertrophy: pathogenesis, detection, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

PGI2-receptors and molecular mechanisms in platelets and vasculature: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Acute antihypertrophic actions of bradykinin in the rat heart: importance of cyclic GMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Actions of vanadate on arachidonic acid metabolism by cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Primary pulmonary hypertension: Current therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

New physiological and pathophysiological aspects on the thromboxane A(2)-prostacyclin regulatory system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Pharmacodynamic profile of prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00725.2003

10.1152/AJPHEART.00725.2003

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15072955%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference